- Branched-chain amino acid - Wikipedia
- BCAAs: Everything You Need to Know
- Branched-chain amino acid
- Product Details
Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. Rev Gastroenterol Mex. Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation. Le Cornu, F. McKiernan, S. Kapadia, et al. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation.
Moreno, P. Deltenre, C. Senterre, et al. Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids. Kawaguchi, N. Izumi, M. Charlton, et al.
Branched-chain amino acid - Wikipedia
Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Plauth, T. Branched-chain amino acids in liver disease: new aspects of long known phenomena.
- A Nonlinear dynamics perspective of Wolfram’s new kind of science Part I: Threshold Of Complexity.
- The Way of Water and Sprouts of Virtue.
- GU Rewards.
Marchesini, G. Bianchi, M. Merli, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Early administration of branched-chain amino acid granules. World J Gastroenterol. Les, E. Doval, R. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: A randomized study. Am J Gastroenterol. Amodio, C. Bemeur, R. Butterworth, et al.
The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Ichikawa, T. Okabayashi, H. Maeda, et al. Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study.
Surg Today. Gluud, G. Dam, M. Borre, et al.
BCAAs: Everything You Need to Know
Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?. Metab Brain Dis. Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.
Nishikawa, Y. Osaki, T. Inuzuka, et al. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.
Branched-chain amino acid
Lee, J. Seong, J. Bae, et al. Cancer Res Treat. Ishihara, M. Iwasa, H. Tanaka, et al. Effect of branched-chain amino acids in patients receiving intervention for hepatocellular carcinoma. Takeshita, T. Ichikawa, K. Nakao, et al. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
Nutr Res. Yoshiji, R.
- Principles, Methods and Application of Particle Size Analysis.
- Please confirm you are human.
- Whiplash (Dreamland, Book 11).
Noguchi, T. Namisaki, et al. Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance. Oncol Rep. Matsumura, Y. Morinaga, S. Fujitani, et al.
Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver. Hepatol Res.
Muto, S. Sato, A. Watanabe, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Soriano, E. El reto de la calidad de vida en pacientes con cirrosis.